Home/Filings/4/0001171843-17-004001
4//SEC Filing

Sucampo Pharmaceuticals, Inc. 4

Accession 0001171843-17-004001

CIK 0001365216operating

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:40 PM ET

Size

5.0 KB

Accession

0001171843-17-004001

Insider Transaction Report

Form 4
Period: 2017-06-30
Driggs Alex
General Counsel & Corp. Sec.
Transactions
  • Award

    Common Stock, Class A (ESPP)

    2017-06-30$8.93/sh+672$6,001672 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period April 1, 2017 through June 30, 2017. This transaction is exempt under Rule 16(b)-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased at 85% of the June 30, 2017 closing price of the issuer's common stock.

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeoperating

Related Parties

1
  • filerCIK 0001365216

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:40 PM ET
Size
5.0 KB